Accurate Investment Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Accurate Investment Solutions’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,543	Closed	-$253K	–	49
2020 Q1	$253K	Buy	4,543 +3,461	+320%	+$212K	0.21%	69
2019 Q4	$69K	Buy	1,082 +1,005	+1,305%	+$57.6K	0.05%	154
2019 Q3	$4K	Hold	77	–	–	﹤0.01%	288
2019 Q2	$4K	Hold	77	–	–	﹤0.01%	290
2019 Q1	$4K	Hold	77	–	–	﹤0.01%	281
2018 Q4	$4K	Hold	77	–	–	﹤0.01%	250
2018 Q3	$5K	Hold	77	–	–	﹤0.01%	274
2018 Q2	$4K	Hold	77	–	–	﹤0.01%	355
2018 Q1	$5K	Hold	77	–	–	﹤0.01%	323
2017 Q4	$5K	Hold	77	–	–	﹤0.01%	313
2017 Q3	$5K	Sell	77 -274	-78%	-$16K	﹤0.01%	314
2017 Q2	$20K	Buy	351 +2	+0.6%	+$109	0.02%	181
2017 Q1	$19K	Sell	349 -131	-27%	-$7.18K	0.02%	169
2016 Q4	$28K	Buy	480 +2	+0.4%	+$109	0.02%	149
2016 Q3	$26K	Buy	478 +2	+0.4%	+$128	0.02%	147
2016 Q2	$35K	Buy	476 +1	+0.2%	+$71	0.04%	126
2016 Q1	$30K	Buy	475 +2	+0.4%	+$126	0.03%	191
2015 Q4	$33K	Buy	+473	New	+$31.3K	0.03%	139

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Accurate Investment Solutions's BMY Position: Q2 2020 in Review

Accurate Investment Solutions sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 4,543 shares — an estimated $253K sold.

Accurate Investment Solutions first reported a position in BMY in Q4 2015 and held it in 18 quarters. The position peaked at $253K in Q1 2020. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Accurate Investment Solutions reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Accurate Investment Solutions sold 4,543 Bristol-Myers Squibb shares in Q2 2020, an estimated $253K.
Accurate Investment Solutions first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 18 quarters.
Accurate Investment Solutions's Bristol-Myers Squibb position peaked at $253K in Q1 2020.
2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.